Effect of age on survival benefit of adjuvant chemotherapy in elderly patients with stage III colon cancer

Journal of the American Geriatrics Society

Volumn 57, Issue 8, 2009, Pages 1403-1410

  Zuckerman, Ilene H ^a   Rapp, Thomas ^a   Onukwugha, Ebere ^a   Davidoff, Amy ^a   Choti, Michael A ^b   Gardner, James ^a   Seal, Brian ^c   Mullins, C Daniel ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF PHARMACY   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c SANOFI   (France)

Author keywords

Elderly; SEER; Stage III colon cancer; Survival

Indexed keywords

FLUOROURACIL; FOLINIC ACID;

ADVANCED CANCER; AGE DISTRIBUTION; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER SURGERY; CANCER SURVIVAL; COHORT ANALYSIS; COLON CANCER; ELDERLY CARE; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; RETROSPECTIVE STUDY; RISK BENEFIT ANALYSIS;

AGE FACTORS; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMOTHERAPY, ADJUVANT; COLONIC NEOPLASMS; FEMALE; FLUOROURACIL; HUMANS; LEUCOVORIN; LOGISTIC MODELS; MALE; MEDICARE; NEOPLASM STAGING; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; SEER PROGRAM; SURVIVAL ANALYSIS; TREATMENT OUTCOME; UNITED STATES;

EID: 68149145498     PISSN: 00028614     EISSN: 15325415     Source Type: Journal    
DOI: 10.1111/j.1532-5415.2009.02355.x     Document Type: Article

References (33)

1. Wolpin BM, Meyerhardt JA, Mamon HJ et al. Adjuvant treatment of colorectal cancer. CA Cancer J Clin 2007 57 : 168 185.
2. Sundararajan V, Mitra N, Jacobson JS et al. Survival associated with 5-fluorouracil-based adjuvant chemotherapy among elderly patients with node-positive colon cancer. Ann Intern Med 2002 136 : 349 357.
3. Vogelaar I, van Ballegooijen M, Schrag D et al. How much can current interventions reduce colorectal cancer mortality in the U.S.? Mortality projections for scenarios of risk-factor modification, screening, and treatment. Cancer 2006 107 : 1624 1633.
4. Micheli A, Yancik R, Krogh V et al. Contrasts in cancer prevalence in Connecticut, Iowa, and Utah. Cancer 2002 95 : 430 439.
5. Yancik R, Ries LA. Aging and cancer in America. Demographic and epidemiologic perspectives. Hematol Oncol Clin North Am 2000 14 : 17 23.
6. Schrag D, Gelfand SE, Bach PB et al. Who gets adjuvant treatment for stage II and III rectal cancer? Insight from surveillance, epidemiology, and end results - Medicare. J Clin Oncol 2001 19 : 3712 3718.
7. Bradley CJ, Given CW, Dahman B et al. Adjuvant chemotherapy after resection in elderly Medicare and Medicaid patients with colon cancer. Arch Intern Med 2008 168 : 521 529.
8. Dobie SA, Baldwin LM, Dominitz JA et al. Completion of therapy by Medicare patients with stage III colon cancer. J Natl Cancer Inst 2006 98 : 610 619.
9. Dobie SA, Warren JL, Matthews B et al. Survival benefits and trends in use of adjuvant therapy among elderly stage II and III rectal cancer patients in the general population. Cancer 2008 112 : 789 799.
10. Lemmens VE, van Halteren AH, Janssen-Heijnen ML et al. Adjuvant treatment for elderly patients with stage III colon cancer in the southern Netherlands is affected by socioeconomic status, gender, and comorbidity. Ann Oncol 2005 16 : 767 772.
11. Hershman D, Hall MJ, Wang X et al. Timing of adjuvant chemotherapy initiation after surgery for stage III colon cancer. Cancer 2006 107 : 2581 2588. (Pubitemid 44845611)
12. John V, Mashru S, Lichtman S. Pharmacological factors influencing anticancer drug selection in the elderly. Drugs Aging 2003 20 : 737 759.
13. Gross CP, Guo Z, McAvay GJ et al. Multimorbidity and survival in older persons with colorectal cancer. J Am Geriatr Soc 2006 54 : 1898 1904.
14. Schrag D, Cramer LD, Bach PB et al. Age and adjuvant chemotherapy use after surgery for stage III colon cancer. J Natl Cancer Inst 2001 93 : 850 857.
15. Golfinopoulos V, Pentheroudakis G, Pavlidis N. Treatment of colorectal cancer in the elderly: A review of the literature. Cancer Treat Rev 2006 32 : 1 8.
16. Arora A, Potter J. Older patients with colon cancer: Is adjuvant chemotherapy safe and effective? J Am Geriatr Soc 2003 51 : 567 569.
17. Potosky AL, Harlan LC, Kaplan RS et al. Age, sex, and racial differences in the use of standard adjuvant therapy for colorectal cancer. J Clin Oncol 2002 20 : 1192 1202.
18. Sargent DJ, Goldberg RM, Jacobson SD et al. A pooled analysis of adjuvant chemotherapy for resected colon cancer in elderly patients. N Engl J Med 2001 345 : 1091 1097.
19. Gill S, Loprinzi CL, Sargent DJ et al. Pooled analysis of fluorouracil-based adjuvant therapy for stage II and III colon cancer: Who benefits and by how much? J Clin Oncol 2004 22 : 1797 1806.
20. Jessup JM, Stewart A, Greene FL et al. Adjuvant chemotherapy for stage III colon cancer: Implications of race/ethnicity, age, and differentiation. JAMA 2005 294 : 2703 2711.
21. Mayo-Clinic. 2008 October, 31. Mayo Foundation for Medical Education and Research: Adjuvant systemic therapy for resected colon cancer -Determining treatment benefits for colon cancer patients receiving adjuvant chemotherapy. Mayo Foundation for Medical Education and Research [on-line]. Available at Accessed October 31, 2008.
22. Iwashyna TJ, Lamont EB. Effectiveness of adjuvant fluorouracil in clinical practice: A population-based cohort study of elderly patients with stage III colon cancer. J Clin Oncol 2002 20 : 3992 3998.
23. Saltz LB, Niedzwiecki D, Hollis D et al. Irinotecan fluorouracil plus leucovorin is not superior to fluorouracil plus leucovorin alone as adjuvant treatment for stage III colon cancer: Results of CALGB 89803. J Clin Oncol 2007 25 : 3456 3461.
24. Greene WH. Econometric Analysis. Upper Saddle River, NJ : Prentice Hall, 2007.
25. Parsons LS. Reducing Bias in a Propensity Score Matched-Pair Sample Using Greedy Matching Techniques. Cary, NC : SAS Institute, 2001, pp 214 226.
26. CMS. 2008 August, 27. Medicare Part B Reference Manual July 2003, Revision 057 Appendix D [on-line]. Available at Accessed August 27, 2008.
27. McGory ML. Quality indicators for the care of colorectal cancer in vulnerable elders. J Am Geriatr Soc 2007 55 (Suppl 2) : S277 S284.
28. Charlson ME, Pompei P, Ales KL et al. A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. J Chronic Dis 1987 40 : 373 383.
29. Prentice RL, Gloeckler LA. Regression analysis of grouped survival data with application to breast cancer data. Biometrics 1978 34 : 57 67.
30. Allison PD. Survival Analysis Using the SAS System: A Practical Guide. Cary NC : SAS Press, 1995.
31. Gupta SK, Lamont EB. Patterns of presentation, diagnosis, and treatment in older patients with colon cancer and comorbid dementia. J Am Geriatr Soc 2004 52 : 1681 1687.
32. Berkowitz Z, Hawkins NA, Peipins LA et al. Beliefs, risk perceptions, and gaps in knowledge as barriers to colorectal cancer screening in older adults. J Am Geriatr Soc 2008 56 : 307 314.
33. Elkin EB, Kim SH, Casper ES et al. Desire for information and involvement in treatment decisions: Elderly cancer patients' preferences and their physicians' perceptions. J Clin Oncol 2007 25 : 5275 5280.